SEATTLE-November 16, 2022 -(BUSINESS WIRE)–Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $26 million Series A1 financing round. This brings total funding raised in 2022 to $86M for the…Read More
FLG and its partners deliver truly exceptional value. I have had the pleasure to work with three FLG partners—Mike Gennaro, John Finegan, and most recently Eric Hall—in both the SaaS and Life Sciences industries. Their ability to seamlessly integrate into operations and quickly develop a deep understanding of the company was particularly impressive. Each provided meaningful leadership and thoughtful guidance for the finance function, delivering both tactical and strategic value, including during times of company transition. They partnered with management to win, drove financing activities to successful conclusion, and were tireless in their dedication to company objectives.
Lisa Barbot, Current Principal Attorney, Barbot Law Read More